Merck’s promotion of Gardasil, its vaccine against the human papilloma virus (HPV), has a complicated history. First there was the exuberant claim about its reputedly great effectiveness in preventing cervical cancer. Now comes the recommendation last month from the Centers for Disease … Continue reading
Testing women for human papillomavirus (HPV) may catch more pre-cancerous growths than standard cervical cancer screening does—but more evidence is needed before the newer tests become routine, a study published Monday concludes. The report, in the Annals of Internal Medicine, … Continue reading
NEW YORK (Reuters Health) – Testing women for human papillomavirus (HPV) may catch more pre-cancerous growths than standard cervical cancer screening does — but more evidence is needed before the newer tests become routine, a study published Monday concludes. The … Continue reading